Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Forecast

The non-steroidal anti-inflammatory drugs (NSAIDs) market is expected to increase significantly, growing from USD 21.01 billion in 2023 to approximately USD 33.55 billion by 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% from 2024 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5132

Report Highlights:

• Arthritis, an inflammatory bone disorder remains the most prevalent target capturing 38% of the market share in 2023.
• The oral route of administration reigns supreme with a 56% market share in 2023 due to its convenience.
• Retail pharmacies lead the pack with a commanding 46% market share in 2023.
• North America leads the way in the NSAIDs market.

The Centers for Disease Control and Prevention reports roughly 1 in 5 adults in the U.S., around 53.2 million people, have arthritis. It’s more common in women (20.9%) than men (16.3%). Nonsteroidal anti-inflammatory drugs are highly recommended for managing the pain.

Non-steroidal anti-inflammatory drugs are commonly used to relieve pain, reduce inflammation, and lower fever. They are widely used to treat arthritis, muscle aches, headaches, menstrual cramps, and minor injuries like sprains and strains. NSAIDs block the production of chemicals in the body called prostaglandins, which are responsible for pain and inflammation.

These medications are often found in over-the-counter forms like ibuprofen (Advil, Motrin), naproxen (Aleve), and prescription-strength versions. NSAIDs are usually available in oral form, but some can be applied topically as creams or gels for localized pain relief.

Key Companies in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

Several major companies are shaping the non-steroidal anti-inflammatory drugs (NSAIDs) market, including:

• Pfizer Inc.: A global leader in the pharmaceutical industry, Pfizer is known for its extensive portfolio of pain management medications, including NSAIDs.
• Merck & Co., Inc.: Merck is a multinational healthcare company that produces a wide range of NSAIDs used for pain relief and inflammation treatment.
• Novartis AG: Headquartered in Switzerland, Novartis offers a variety of NSAID products aimed at addressing pain and inflammatory conditions.
• GlaxoSmithKline Plc: GSK, based in the UK, is a key player in the NSAID market, providing over-the-counter and prescription pain relief medications.
• Johnson & Johnson Services Inc.: J&J is known for its innovative pharmaceutical solutions, including NSAIDs that help manage pain and reduce inflammation.
• Bayer AG: This German multinational pharmaceutical and life sciences company produces several well-known NSAID brands.
• Dr. Reddy’s Laboratories Ltd.: An Indian pharmaceutical company that manufactures and distributes generic NSAIDs, offering affordable pain relief options worldwide.
• Viatris Inc.: A global healthcare company known for its wide range of generic medications, including NSAIDs for pain and inflammation.
• AstraZeneca: A leading biopharmaceutical company, AstraZeneca is involved in producing NSAIDs as part of its portfolio for managing pain and related conditions.
• Abbott Laboratories: Abbott provides a variety of healthcare products, including NSAIDs that are widely used for pain management and inflammation control.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/non-steroidal-anti-inflammatory-drugs-market-sizing

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5132

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Healthcare Web Wire is a premier subsidiary of Towards Healthcare, dedicated to providing comprehensive insights and information related to the healthcare industry. With a commitment to delivering accurate and timely updates, Healthcare Web Wire serves as a vital resource for professionals, enthusiasts, and stakeholders within the healthcare sector. Our platform serves as a central hub for the latest news, trends and developments shaping the healthcare landscape. Join us on Healthcare Web Wire and become part of a vibrant community dedicated to advancing healthcare knowledge and shaping the future of healthcare worldwide.

Visit Dental Specifics: https://www.towardsdental.com

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare